1. Home
  2. ROAD vs RGEN Comparison

ROAD vs RGEN Comparison

Compare ROAD & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Construction Partners Inc.

ROAD

Construction Partners Inc.

HOLD

Current Price

$111.87

Market Cap

6.7B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$111.38

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROAD
RGEN
Founded
2001
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.6B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
ROAD
RGEN
Price
$111.87
$111.38
Analyst Decision
Strong Buy
Buy
Analyst Count
5
12
Target Price
$127.80
$167.67
AVG Volume (30 Days)
495.5K
1.3M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
286.96
EPS
0.47
0.15
Revenue
$785,679,000.00
$141,236,000.00
Revenue This Year
$27.79
$14.30
Revenue Next Year
$10.29
$14.52
P/E Ratio
$234.17
$724.87
Revenue Growth
0.31
35.10
52 Week Low
$93.22
$100.99
52 Week High
$151.00
$175.77

Technical Indicators

Market Signals
Indicator
ROAD
RGEN
Relative Strength Index (RSI) 40.42 43.94
Support Level $102.84 N/A
Resistance Level $118.05 $129.77
Average True Range (ATR) 6.63 6.03
MACD -2.47 -1.08
Stochastic Oscillator 7.42 32.66

Price Performance

Historical Comparison
ROAD
RGEN

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: